Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Anaphylaxis Update

By Bobby Quentin Lanier, M.D. | on March 1, 2013 | 2 Comments
From the College
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

However, anaphylaxis may present as an acute cardiac or respiratory event, or with hypotension as the only manifestation.8 The onset of symptoms varies from a few seconds or minutes after contact with the elicitor to several hours (depending on the route of exposure and degree of sensitization),16 but the majority of events occur within two hours of exposure.18

You Might Also Like
  • Recent studies suggest that the prevalence of food allergy has increased over the past 2 decades
  • Biphasic Allergic Reactions: Observation, Treatment Guidelines
  • FDA Changes Epinephrine Label, Revises Dosage Instructions for Anaphylaxis, Cardiac Arrest
Explore This Issue
ACEP News: Vol 32 – No 03 – March 2013

The faster anaphylaxis develops, the more likely the reaction is to be severe and potentially life-threatening.8 A pattern of biphasic anaphylaxis has also been described in which symptoms recur after the apparent resolution of the initial episode, which merits treatment similar to the initial episode.8,19

Anaphylaxis is estimated to be fatal in 0.7% to 2% of cases.20,21 Death can occur within minutes of the onset of symptoms.7 Deaths due to anaphylaxis are usually attributed to respiratory obstruction or cardiovascular collapse, or both.11,22

Anaphylaxis Triggers

Food is the major cause of anaphylaxis in the United States,2 with recent data associating severe reactions, most commonly in children, with allergy to tree nuts, peanuts, shellfish, soy, and fin fish.23 Medicines are among the leading causes of anaphylaxis, with beta-lactam antibiotics most commonly implicated.8,10,15,24,25 Anaphylactic reactions to insect stings have occurred in 1% of children and 3% of adults8,26,27 and are associated with a high probability of recurrence.28

Other important causes of anaphylaxis include latex allergy15,29 and perioperative anaphylaxis.8,10,30

Managing Anaphylaxis

Prompt recognition and management of the signs and symptoms of anaphylaxis are the key to managing anaphylaxis.8

Immediate interventions for patients experiencing anaphylaxis include assessment of airway and breathing, circulation, and level of consciousness; administration of intramuscular epinephrine; and placement of the patient in a supine position in order to slow the progression of hemodynamic compromise.8

Intramuscular (IM) epinephrine injection is first-line treatment in all cases of anaphylaxis.4,8,22 Along with the use of oxygen, is considered the most important therapeutic agent administered for anaphylaxis.8 The appropriate dose of IM epinephrine should be administered immediately at the onset of symptoms, even if the diagnosis is uncertain.4,8,22 At a concentration of 1:1000, the recommended dose of epinephrine via auto-injector is 0.15 mg for patients weighing 10-25 kg and 0.3 mg for patients weighing greater than 25 kg.4

Epinephrine may be administered every 5 to 15 minutes as necessary, and if symptoms progress or recur (i.e., biphasic reaction), repeat epinephrine dosing is recommended over adjunctive treatments.4,8 Although up to a third of patients require more than one dose,31 additional measures (intravenous epinephrine, volume replacement, vasopressors) may be needed in patients not responding to multiple doses.8

Pages: 1 2 3 4 | Single Page

Topics: AllergyCardiovascularClinical GuidelineCritical CareDiagnosisEmergency MedicineEmergency PhysicianImmune SystemPatient Safety

Related

  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Q&A with ACEP President L. Anthony Cirillo

    November 5, 2025 - 0 Comment
  • Overcoming Language Barriers in the Emergency Department

    October 21, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

2 Responses to “Anaphylaxis Update”

  1. July 22, 2014

    Articles on anaphylaxis and diagnosis thereof | Mastopedia Research Feed Reply

    […] https://www.acepnow.com/article/anaphylaxis-update/ […]

  2. March 26, 2015

    Anaphylaxis Update | Mastopedia Research Feed Reply

    […] https://www.acepnow.com/article/anaphylaxis-update/ […]

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603